BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 19050039)

  • 21. Essential role of TRPV2 ion channel in the sensitivity of dystrophic muscle to eccentric contractions.
    Zanou N; Iwata Y; Schakman O; Lebacq J; Wakabayashi S; Gailly P
    FEBS Lett; 2009 Nov; 583(22):3600-4. PubMed ID: 19840792
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Full-length dystrophin gene transfer to the mdx mouse in utero.
    Reay DP; Bilbao R; Koppanati BM; Cai L; O'Day TL; Jiang Z; Zheng H; Watchko JF; Clemens PR
    Gene Ther; 2008 Apr; 15(7):531-6. PubMed ID: 18273052
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Histological parameters for the quantitative assessment of muscular dystrophy in the mdx-mouse.
    Briguet A; Courdier-Fruh I; Foster M; Meier T; Magyar JP
    Neuromuscul Disord; 2004 Oct; 14(10):675-82. PubMed ID: 15351425
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dp71 can restore the dystrophin-associated glycoprotein complex in muscle but fails to prevent dystrophy.
    Cox GA; Sunada Y; Campbell KP; Chamberlain JS
    Nat Genet; 1994 Dec; 8(4):333-9. PubMed ID: 7894482
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PI3-kinase promotes TRPV2 activity independently of channel translocation to the plasma membrane.
    Penna A; Juvin V; Chemin J; Compan V; Monet M; Rassendren FA
    Cell Calcium; 2006 Jun; 39(6):495-507. PubMed ID: 16533525
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Disruption of muscle membrane and phenotype divergence in two novel mouse models of dysferlin deficiency.
    Ho M; Post CM; Donahue LR; Lidov HG; Bronson RT; Goolsby H; Watkins SC; Cox GA; Brown RH
    Hum Mol Genet; 2004 Sep; 13(18):1999-2010. PubMed ID: 15254015
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Systemic administration of L-arginine benefits mdx skeletal muscle function.
    Barton ER; Morris L; Kawana M; Bish LT; Toursel T
    Muscle Nerve; 2005 Dec; 32(6):751-60. PubMed ID: 16116642
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TRP channels in normal and dystrophic skeletal muscle.
    Gailly P
    Curr Opin Pharmacol; 2012 Jun; 12(3):326-34. PubMed ID: 22349418
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Resveratrol ameliorates muscular pathology in the dystrophic mdx mouse, a model for Duchenne muscular dystrophy.
    Hori YS; Kuno A; Hosoda R; Tanno M; Miura T; Shimamoto K; Horio Y
    J Pharmacol Exp Ther; 2011 Sep; 338(3):784-94. PubMed ID: 21652783
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In situ measurements of calpain activity in isolated muscle fibres from normal and dystrophin-lacking mdx mice.
    Gailly P; De Backer F; Van Schoor M; Gillis JM
    J Physiol; 2007 Aug; 582(Pt 3):1261-75. PubMed ID: 17510188
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Measurement of sub-membrane [Ca2+] in adult myofibers and cytosolic [Ca2+] in myotubes from normal and mdx mice using the Ca2+ indicator FFP-18.
    Han R; Grounds MD; Bakker AJ
    Cell Calcium; 2006 Sep; 40(3):299-307. PubMed ID: 16765438
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Exogenous Dp71 restores the levels of dystrophin associated proteins but does not alleviate muscle damage in mdx mice.
    Greenberg DS; Sunada Y; Campbell KP; Yaffe D; Nudel U
    Nat Genet; 1994 Dec; 8(4):340-4. PubMed ID: 7894483
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Disodium cromoglycate protects dystrophin-deficient muscle fibers from leakiness.
    Marques MJ; Ventura Machado R; Minatel E; Santo Neto H
    Muscle Nerve; 2008 Jan; 37(1):61-7. PubMed ID: 17724738
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Defective membrane repair in dysferlin-deficient muscular dystrophy.
    Bansal D; Miyake K; Vogel SS; Groh S; Chen CC; Williamson R; McNeil PL; Campbell KP
    Nature; 2003 May; 423(6936):168-72. PubMed ID: 12736685
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Animal models of muscular dystrophies.
    Nonaka I
    Lab Anim Sci; 1998 Feb; 48(1):8-17. PubMed ID: 9517883
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum CK, calcium, magnesium, and oxidative phosphorylation in mdx mouse muscular dystrophy.
    Glesby MJ; Rosenmann E; Nylen EG; Wrogemann K
    Muscle Nerve; 1988 Aug; 11(8):852-6. PubMed ID: 3173410
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early adenovirus-mediated gene transfer effectively prevents muscular dystrophy in alpha-sarcoglycan-deficient mice.
    Allamand V; Donahue KM; Straub V; Davisson RL; Davidson BL; Campbell KP
    Gene Ther; 2000 Aug; 7(16):1385-91. PubMed ID: 10981665
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phospholipase A2-derived lysophosphatidylcholine triggers Ca2+ entry in dystrophic skeletal muscle fibers.
    Boittin FX; Shapovalov G; Hirn C; Ruegg UT
    Biochem Biophys Res Commun; 2010 Jan; 391(1):401-6. PubMed ID: 19914213
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Calcium entry through stretch-inactivated ion channels in mdx myotubes.
    Franco A; Lansman JB
    Nature; 1990 Apr; 344(6267):670-3. PubMed ID: 1691450
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Blockade of TRPV2 is a Novel Therapy for Cardiomyopathy in Muscular Dystrophy.
    Iwata Y; Matsumura T
    Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31394715
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.